Drawing for EDGE

USPTO serial 99830347

EDGE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
BODRI, KRISTIN MARIE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with EDGE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

ROBERT REYNOLDS

ROBERT REYNOLDS KLINTWORTH & ROZENBLAT LLP2045 W. Grand AveSte. B. PMB 84396Chicago, IL 60612

Goods and services

ClassDescriptionStatusFirst use
005Veterinary pharmaceutical preparations for the prevention of diabetes in animals via gene edited stem cells; Veterinary pharmaceutical preparations for the treatment of diabetes in animals via gene edited stem cells; Veterinary vaccines for poultryACTIVE—
035Retail store services featuring poultry vaccines and veterinary pharmaceutical preparations in the nature of gene edited stem cells for the treatment of diabetes in animals; On-line retail store services featuring poultry vaccines and veterinary pharmaceutical preparations in the nature of gene edited stem cells for the treatment of diabetes in animalsACTIVE—
042Research and development in the field of veterinary poultry vaccines and veterinary pharmaceuticals utilizing advancements in gene editing and stem cells in biotechnology for the treatment and prevention of diabetes in animalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 20, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 20, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 14, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 19, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 17, 2026DOCKASSIGNED TO EXAMINER—
Sep 16, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 18, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
May 18, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance